Friday Morning Live Cases: Coronary and Structural Interventions
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided...Read More
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided training for thousands of interventional cardiologists from the United States and abroad since 1981.
The meeting’s mission is to engage interventional cardiologists and cardiac surgeons specializing in coronary and structural heart disease to further enhance the care of their patients, mentor and train future generations of cardiovascular specialists, and lead front-line clinical research in the field.
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount...
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.
Kendra J Grubb, M.D., M.H.A, F.A.C.C joined the Emory faculty in 2018. She is an Associate Profesor, Department of...
Kendra J Grubb, M.D., M.H.A, F.A.C.C joined the Emory faculty in 2018. She is an Associate Profesor, Department of Surgery, and serves as the Surgical Director of the Structural Heart and Valve Center. She completed a fellowship in cardiothoracic surgery at the University of Virginia in 2012 and subsequenlty trained in interventional cardiology at Columbia University - NYPH.
Michael Slack works at University of Maryland Medical Center, Baltimore, MD, USA.